It is currently Mon Mar 27, 2017 12:47 am
Patients to be told about clinical trials
By Nicholas Timmins, Public Policy Editor
Published: June 24 2008 03:05 | Last updated: June 24 2008 03:05
Patients are to be given the right to be told about clinical trials in a move aimed at making the National Health Service a more attractive place for pharmaceutical and biotechnology companies to do research.
The aim is also to improve patients’ access to innovative drugs ...
1: Maturitas. 2008 Apr 20;59(4):293-303. Epub 2008 Apr 3. Links
One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: Effects on hormonal milieu.Pluchino N, Ninni F, ...
1: FEBS Lett. 2001 Jun 29;500(1-2):52-5. Links
The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines.Krakauer T, Li BQ, Young HA.
Department of Immunology and Molecular Biology, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702-5011, USA. email@example.com
Excessive release of proinflammatory cytokines mediates the toxic effect of superantigenic staphylococcal exotoxins ...
Total posts 237099 • Total topics 25716 • Total members 17008